Transport of thyrotropin releasing hormone from cerebrospinal fluid to hypophysial portal blood and the release of thyrotropin

C. Oliver, N. Ben Jonathan, R. S. Mical, J. C. Porter

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The capacity of the median eminence to transport thyrotropin releasing hormone (TRH) from cerebrospinal fluid (CSF) to hypophysial portal blood, and the ability of TRH when introduced into a lateral ventricle to stimulate TSH release from the pituitary gland were investigated. Male rats were injected either intraventricularly or intravenously with 0, 1, 10, or 100 ng of TRH, and plasma TSH concentrations were determined at various times thereafter. TRH administration via both routes resulted in substantial release of TSH. Following intraventricular injection of TRH, there was a delay in reaching maximal TSH concentration when compared with the faster elevation and faster decline in TSH concentrations which followed intravenous injection of the same dose of TRH. In a second experiment, 7 μCi of [3H] TRH were introduced intraventricularly or intravenously, and hypophysial portal and arterial blood were simultaneously collected and examined for the presence of radioactivity. The intraventricular injection of [3H] TRH resulted in a peak of radioactivity in portal blood within minutes, which was maintained for 20-30 min and then declined. The concentration of radioactivity in arterial blood from the same animals was considerably lower than that in portal blood. The intravenous administration of [3H] TRH resulted in radioactive peaks in both portal and arterial blood with a higher concentration of radioactive substances in arterial blood. However, the level of radioactivity in portal blood following intravenous injection of [3H] TRH comprised no more than 5-10% of that found following intraventricular administration of the same dose. The data support the view that TRH is able to cross the median eminence from CSF into hypophysial portal blood and that it is capable of stimulating the pituitary gland to release TSH.

Original languageEnglish (US)
Pages (from-to)1138-1143
Number of pages6
JournalEndocrinology
Volume97
Issue number5
StatePublished - 1975

Fingerprint

Thyrotropin-Releasing Hormone
Thyrotropin
Cerebrospinal Fluid
Radioactivity
Intraventricular Injections
Median Eminence
Pituitary Gland
Intravenous Injections
Lateral Ventricles
Intravenous Administration

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Transport of thyrotropin releasing hormone from cerebrospinal fluid to hypophysial portal blood and the release of thyrotropin. / Oliver, C.; Ben Jonathan, N.; Mical, R. S.; Porter, J. C.

In: Endocrinology, Vol. 97, No. 5, 1975, p. 1138-1143.

Research output: Contribution to journalArticle

Oliver, C, Ben Jonathan, N, Mical, RS & Porter, JC 1975, 'Transport of thyrotropin releasing hormone from cerebrospinal fluid to hypophysial portal blood and the release of thyrotropin', Endocrinology, vol. 97, no. 5, pp. 1138-1143.
Oliver, C. ; Ben Jonathan, N. ; Mical, R. S. ; Porter, J. C. / Transport of thyrotropin releasing hormone from cerebrospinal fluid to hypophysial portal blood and the release of thyrotropin. In: Endocrinology. 1975 ; Vol. 97, No. 5. pp. 1138-1143.
@article{c41bd9a1e4c54ce8ba80d9c3023c7401,
title = "Transport of thyrotropin releasing hormone from cerebrospinal fluid to hypophysial portal blood and the release of thyrotropin",
abstract = "The capacity of the median eminence to transport thyrotropin releasing hormone (TRH) from cerebrospinal fluid (CSF) to hypophysial portal blood, and the ability of TRH when introduced into a lateral ventricle to stimulate TSH release from the pituitary gland were investigated. Male rats were injected either intraventricularly or intravenously with 0, 1, 10, or 100 ng of TRH, and plasma TSH concentrations were determined at various times thereafter. TRH administration via both routes resulted in substantial release of TSH. Following intraventricular injection of TRH, there was a delay in reaching maximal TSH concentration when compared with the faster elevation and faster decline in TSH concentrations which followed intravenous injection of the same dose of TRH. In a second experiment, 7 μCi of [3H] TRH were introduced intraventricularly or intravenously, and hypophysial portal and arterial blood were simultaneously collected and examined for the presence of radioactivity. The intraventricular injection of [3H] TRH resulted in a peak of radioactivity in portal blood within minutes, which was maintained for 20-30 min and then declined. The concentration of radioactivity in arterial blood from the same animals was considerably lower than that in portal blood. The intravenous administration of [3H] TRH resulted in radioactive peaks in both portal and arterial blood with a higher concentration of radioactive substances in arterial blood. However, the level of radioactivity in portal blood following intravenous injection of [3H] TRH comprised no more than 5-10{\%} of that found following intraventricular administration of the same dose. The data support the view that TRH is able to cross the median eminence from CSF into hypophysial portal blood and that it is capable of stimulating the pituitary gland to release TSH.",
author = "C. Oliver and {Ben Jonathan}, N. and Mical, {R. S.} and Porter, {J. C.}",
year = "1975",
language = "English (US)",
volume = "97",
pages = "1138--1143",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Transport of thyrotropin releasing hormone from cerebrospinal fluid to hypophysial portal blood and the release of thyrotropin

AU - Oliver, C.

AU - Ben Jonathan, N.

AU - Mical, R. S.

AU - Porter, J. C.

PY - 1975

Y1 - 1975

N2 - The capacity of the median eminence to transport thyrotropin releasing hormone (TRH) from cerebrospinal fluid (CSF) to hypophysial portal blood, and the ability of TRH when introduced into a lateral ventricle to stimulate TSH release from the pituitary gland were investigated. Male rats were injected either intraventricularly or intravenously with 0, 1, 10, or 100 ng of TRH, and plasma TSH concentrations were determined at various times thereafter. TRH administration via both routes resulted in substantial release of TSH. Following intraventricular injection of TRH, there was a delay in reaching maximal TSH concentration when compared with the faster elevation and faster decline in TSH concentrations which followed intravenous injection of the same dose of TRH. In a second experiment, 7 μCi of [3H] TRH were introduced intraventricularly or intravenously, and hypophysial portal and arterial blood were simultaneously collected and examined for the presence of radioactivity. The intraventricular injection of [3H] TRH resulted in a peak of radioactivity in portal blood within minutes, which was maintained for 20-30 min and then declined. The concentration of radioactivity in arterial blood from the same animals was considerably lower than that in portal blood. The intravenous administration of [3H] TRH resulted in radioactive peaks in both portal and arterial blood with a higher concentration of radioactive substances in arterial blood. However, the level of radioactivity in portal blood following intravenous injection of [3H] TRH comprised no more than 5-10% of that found following intraventricular administration of the same dose. The data support the view that TRH is able to cross the median eminence from CSF into hypophysial portal blood and that it is capable of stimulating the pituitary gland to release TSH.

AB - The capacity of the median eminence to transport thyrotropin releasing hormone (TRH) from cerebrospinal fluid (CSF) to hypophysial portal blood, and the ability of TRH when introduced into a lateral ventricle to stimulate TSH release from the pituitary gland were investigated. Male rats were injected either intraventricularly or intravenously with 0, 1, 10, or 100 ng of TRH, and plasma TSH concentrations were determined at various times thereafter. TRH administration via both routes resulted in substantial release of TSH. Following intraventricular injection of TRH, there was a delay in reaching maximal TSH concentration when compared with the faster elevation and faster decline in TSH concentrations which followed intravenous injection of the same dose of TRH. In a second experiment, 7 μCi of [3H] TRH were introduced intraventricularly or intravenously, and hypophysial portal and arterial blood were simultaneously collected and examined for the presence of radioactivity. The intraventricular injection of [3H] TRH resulted in a peak of radioactivity in portal blood within minutes, which was maintained for 20-30 min and then declined. The concentration of radioactivity in arterial blood from the same animals was considerably lower than that in portal blood. The intravenous administration of [3H] TRH resulted in radioactive peaks in both portal and arterial blood with a higher concentration of radioactive substances in arterial blood. However, the level of radioactivity in portal blood following intravenous injection of [3H] TRH comprised no more than 5-10% of that found following intraventricular administration of the same dose. The data support the view that TRH is able to cross the median eminence from CSF into hypophysial portal blood and that it is capable of stimulating the pituitary gland to release TSH.

UR - http://www.scopus.com/inward/record.url?scp=0016772557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016772557&partnerID=8YFLogxK

M3 - Article

VL - 97

SP - 1138

EP - 1143

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 5

ER -